Garadacimab significantly reduces frequency of hereditary angioedema exacerbations
1. Garadacimab significantly reduced the number of monthly attacks in patients with hereditary...
Read MoreMar 17, 2022
1. Garadacimab significantly reduced the number of monthly attacks in patients with hereditary...
Read MoreMar 16, 2022
1. In a retrospective cohort of about 11,000 children with at least one blood lead level above 4...
Read MoreMar 16, 2022
1. Three Covid-19 vaccines from Pfizer, Moderna, and Johnson & Johnson provided durable...
Read MoreMar 16, 2022
1. Substance use in the prenatal period may be associated with an increased risk of an Attention...
Read MoreMar 16, 2022
1. There was no evidence of superiority among the different antipsychotics. 2. Choice of...
Read MoreMar 15, 2022
1. Patients with low-risk thyroid cancer undergoing thyroidectomy, who did not receive radioiodine...
Read MoreMar 15, 2022
1. For patients referred for potential obstructive coronary artery disease (CAD), computed...
Read MoreMar 12, 2022
1. This study showed that more pro-inflammatory diets led to higher wake-after-sleep-onset (WASO)...
Read MoreMar 11, 2022
1. In this randomized controlled trial, combined treatment with varenicline and nicotine patch...
Read MoreMar 9, 2022
1. Melioidosis, caused by Burkholderia pseudomallei, is rarely diagnosed in the US, and patients...
Read MoreMar 9, 2022
1. Provision of an inhaled glucocorticoid and instruction on its use led to a significantly lower...
Read MoreMar 9, 2022
1. In both trials, faricimab was demonstrated to be non-inferior to aflibercept at improving...
Read MoreMar 9, 2022
1. For patients undergoing only a coronary-artery bypass grafting (CABG) or aortic-valve...
Read MoreMar 9, 2022
1. In patients with hypertension, intensive blood pressure control to a target of less than 120...
Read MoreMar 9, 2022
1. Faricimab every 8 weeks and faricimab per personalized treatment interval (PTI) were...
Read MoreMar 8, 2022
Association between Treatment for Localized Prostate Cancer and Mental Health Outcomes 1. No...
Read MoreMar 8, 2022
1. Single-dose intramuscular injection of nirsevimab significantly reduced respiratory syncytial...
Read MoreMar 8, 2022
1. The AD26.COV2.S vaccine provided protection against moderate to severe-critical Covid-19. 2....
Read MoreMar 8, 2022
1. A large, retrospective population-based cohort study of over 150, 000 participants found an...
Read MoreMar 8, 2022
1. This systematic review and meta-analysis demonstrated that higher-than-normal body mass index...
Read More